Your request to link to rcsb for Estradiol receptor beta (ER?)

• 1HCP: dna recognition by the oestrogen receptor: from solution to the crystal (10.1016/0969-2126(93)90020-H )
• 1HJ1: rat oestrogen receptor beta ligand-binding domain in complex with pure antioestrogen ici164,384 (10.1016/S0969-2126(01)00568-8 )
• 1L2J: human estrogen receptor beta ligand-binding domain in complex with (r, r)-5,11-cis-diethyl-5,6,11,12-tetrahydrochrysene-2,8-diol
• 1NDE: estrogen receptor beta with selective triazine modulator (10.1021/JM020291H )
• 1QKM: human oestrogen receptor beta ligand-binding domain in complex with partial agonist genistein (10.1093/EMBOJ/18.17.4608 )
• 1QKN: rat oestrogen receptor beta ligand-binding domain in complex with antagonist raloxifene (10.1093/EMBOJ/18.17.4608 )
• 1U3Q: crystal structure of estrogen receptor beta complexed with cl-272 (10.1021/JM049719Y )
• 1U3R: crystal structure of estrogen receptor beta complexed with way-338 (10.1021/JM049719Y )
• 1U3S: crystal structure of estrogen receptor beta complexed with way-797 (10.1021/JM049719Y )
• 1U9E: crystal structure of estrogen receptor beta complexed with way-397 (10.1021/JA047633O )
• 1X76: crystal structure of estrogen receptor beta complexed with way-697 (10.1021/JA047633O )
• 1X78: crystal structure of estrogen receptor beta complexed with way-244 (10.1021/JA047633O )
• 1X7B: crystal structure of estrogen receptor beta complexed with erb-041 (10.1021/JA047633O )
• 1X7J: crystal structure of estrogen receptor beta complexed with genistein (10.1016/J.STR.2004.09.015 )
• 1YY4: crystal structure of estrogen receptor beta complexed with 1-chloro-6-(4-hydroxy-phenyl)-naphthalen-2-ol (10.1021/JM058173S )
• 1YYE: crystal structure of estrogen receptor beta complexed with way-202196 (10.1021/JM058173S )
• 1ZAF: crystal structure of estrogen receptor beta complexed with 3-bromo-6-hydroxy-2-(4-hydroxy-phenyl)-inden-1-one (10.1016/J.BMCL.2005.04.013 )
• 2FSZ: a second binding site for hydroxytamoxifen within the coactivator- binding groove of estrogen receptor beta (10.1073/PNAS.0510596103 )
• 2GIU: human estrogen receptor beta ligand-binding domain in complex with compound 45 (10.1016/J.BMCL.2006.03.098 )
• 2I0G: benzopyrans are selective estrogen receptor beta agonists (serbas) with novel activity in models of benign prostatic hyperplasia (10.1021/JM060491J )
• 2J7X: structure of estradiol-bound estrogen receptor beta lbd in complex with lxxll motif from ncoa5
• 2J7Y: structure of 17-epiestriol-bound estrogen receptor beta lbd in complex with lxxll motif from ncoa5
• 2JJ3: estrogen receptor beta ligand binding domain in complex with a benzopyran agonist (10.1016/J.BMCL.2007.07.009 )
• 2NV7: crystal structure of estrogen receptor beta complexed with way-555 (10.1016/J.BMCL.2006.11.066 )
• 2QTU: estrogen receptor beta ligand-binding domain complexed to a benzopyran ligand (10.1016/J.BMCL.2007.08.009 )
• 2YJD: stapled peptide bound to estrogen receptor beta (10.1021/JA202946K )
• 2YLY: sulfonamides as selective estrogen receptor beta agonists. (10.1016/J.BMCL.2011.08.041 )
• 2Z4B: estrogen receptor beta ligand-binding domain complexed to a benzopyran ligand (10.1016/J.BMCL.2007.06.052 )
• 3OLL: crystal structure of phosphorylated estrogen receptor beta ligand binding domain (10.1002/CBIC.201000532 )
• 3OLS: crystal structure of estrogen receptor beta ligand binding domain (10.1002/CBIC.201000532 )
• 3OMO: fragment-based design of novel estrogen receptor ligands (10.1021/JM1011116 )
• 3OMP: fragment-based design of novel estrogen receptor ligands (10.1021/JM1011116 )
• 3OMQ: fragment-based design of novel estrogen receptor ligands (10.1021/JM1011116 )
• 4AA6: the oestrogen receptor recognizes an imperfectly palindromic response element through an alternative side-chain conformation (10.1016/S0969-2126(01)00150-2 )
• 4J24: estrogen receptor in complex with proline-flanked lxxll peptides (10.1021/JA311748R )
• 4J26: estrogen receptor in complex with proline-flanked lxxll peptides (10.1021/JA311748R )
• 4ZI1: human estrogen receptor beta ligand-binding domain in complex with kb095285 and cia12 coactivator peptide
• 5TOA: crystal structure of er beta bound to estradiol (10.1038/S41598-017-03774-X )